
Polyrizon's Retail Following Booms As Biotech Stock Triples On Manufacturing Deal For Allergy Blocker Trial
This collaboration will supply clinical trial material for Polyrizon’s experimental allergy blocker, PL-14, which is set to enter clinical trials in 2025. First Published Dec 19, 2024, 1:21 AM IST | Last Updated Dec 19, 2024, 1:21 AM IST Shares of …